Rakesh Kumar
About
In The Last Decade
Rakesh Kumar
274 papers receiving 11.4k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Molecular Biology 7.5k
- Oncology 3.7k
- Cancer Research 1.9k
- Cell Biology 1.2k
- Immunology 1.2k
Countries citing papers authored by Rakesh Kumar
This map shows the geographic impact of Rakesh Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakesh Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakesh Kumar more than expected).
Fields of papers citing papers by Rakesh Kumar
This network shows the impact of papers produced by Rakesh Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakesh Kumar. The network helps show where Rakesh Kumar may publish in the future.
Co-authorship network of co-authors of Rakesh Kumar
This figure shows the co-authorship network connecting the top 25 collaborators of Rakesh Kumar. A scholar is included among the top collaborators of Rakesh Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rakesh Kumar. Rakesh Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 82 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 8 | |
| 8 | 17 | |
| 9 | Estimating the burden of 'weighing less': A systematic review and meta-analysis of low birth-weight in India. | 9 |
| 10 | 22 | |
| 11 | PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells | 2 |
| 12 | 15 | |
| 13 | 79 | |
| 14 | 314 | |
| 15 | 96 | |
| 16 | 37 | |
| 17 | 72 | |
| 18 | 74 | |
| 19 | Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors. | 18 |
| 20 | Reduced expression of c-erbB2 gene product in human mammary carcinoma SK-BR-3 cells treated with interferon-gamma and tumor necrosis factor-alpha. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.